News for Healthier Living

Wesper Revolutionizes GLP-1 Sleep Apnea Screening and Enables Personalized Treatment

Wesper, a leader in advanced home sleep apnea testing (HSAT), is transforming how obesity and sleep apnea are managed by integrating groundbreaking biometric sleep data with metabolic health innovations. Following the FDA approval of GLP-1 receptor agonists for sleep apnea treatment, Wesper is working with hospitals and physicians to bridge the gap between obesity, diabetes, GLP-1 medications, and sleep apnea.

February 11, 2025


February 21 2025

February 20 2025

February 19 2025

February 18 2025

February 17 2025

February 16 2025

February 15 2025

February 14 2025

February 13 2025

February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025